AMD3100/Plerixafor overcomes immune inhibition by the CXCL12–KRT19 coating on pancreatic and colorectal cancer cells
Douglas T. Fearon, Tobias Janowitz
Topics & Concepts
CXCR4Immune systemColorectal cancerPancreatic cancerMedicineCancer researchChemokineAdenocarcinomaChemokine receptorPlerixaforPancreatic ductal adenocarcinomaImmunologyCancerOncologyInternal medicineImmunotherapy and Immune ResponsesImmune Cell Function and InteractionChemokine receptors and signaling